Theodoros Karagiotis

St.-Antonius-Hospital Gronau

Papers

7

Total Citations

84

H-Index

5

About

Theodoros Karagiotis is a urologic surgeon and researcher whose work focuses on optimizing outcomes in robot-assisted surgery for prostate and bladder cancers. His research centers on how patient-specific factors—age, obesity, and symptom burden—affect perioperative, functional, and oncological results after robotic radical prostatectomy (RARP). Karagiotis has made key contributions by demonstrating that RARP is feasible and safe in men aged 75 and older, with outcomes comparable to younger patients, and by showing that patients with moderate-to-severe lower urinary tract symptoms experience significant improvements in quality of life post-surgery. His work on obesity’s impact on RARP outcomes and his use of the Comprehensive Complication Index to grade complications after robot-assisted cystectomy have advanced surgical risk assessment. With over 80 citations across his most cited papers, Karagiotis has also explored quality of life using Pentafecta criteria and CAPRA-S risk stratification, providing nuanced insights into patient-reported outcomes. His research, conducted at a high-volume center, offers evidence-based guidance for patient selection and counseling in robotic urologic oncology.

Research Focus

Key Achievements

5
H-Index
7
Papers
84
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility of robot-assisted radical prostatectomy in men at senior age ≥75 years: perioperative, functional, and oncological outcomes of a high-volume center
22 citations · 2021
📈 Most Prolific Year: 2022 (4 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: St.-Antonius-Hospital Gronau

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago